On the first day of work after the holiday, the leaders visited Bai Da Nian.
Release time:
2020-07-22
, the leaders visited the new year
. our newspaper 2# July 12 . on the first day of work after the spring festival, the leaders of the group company paid new year greetings to all the employees of overseas enterprises through the video conference system, and separately visited the subordinate enterprises in Jin to extend holiday greetings to the employees. The management team of
Group Company extended New Year greetings to all employees of overseas enterprises such as Daye Peak and Yunnan Peak through video connection. After
, the leaders of the group company visited the subordinate enterprises of Zaijin separately to understand the implementation of the annual work plan and put forward requirements and hopes for the work in the new year.
Jiang Xiaomeng and other leaders visited the International Trade Company and Jinhua Pharmaceutical Company. At the site of the international trade warehouse and the platform warehouse of the south railway station, Jiang Xiaomeng learned about the renovation of the warehouse area and the inventory of the platform warehouse of the south railway station on the spot, and put forward guidance and requirements on the construction of the new gate of the warehouse, the improvement of the facilities in the warehouse area, and the greening of the warehouse area.
In the communication with the management team of pharmaceutical companies and peak pharmacy, Jiang Xiaomeng asked the management team of pharmaceutical companies to participate in more drug fairs and increase higher-level information channels. Introduce high-end varieties such as foreign capital, Sino-foreign joint ventures and hot-selling health products; Increase the distribution capacity of retail terminals and do a good job in terminal services other than hospitals. Large pharmacies should speed up the development, the management team should change their ideas and concepts, and use innovative business concepts to create characteristic pharmacies.
Yu Jianhong and other leaders visited Jinxi Pharmaceutical Factory, Cable Company and Jianfeng Health Technology Company successively. In Jinxi Factory, Yu Jianhong requires managers at all levels to set up an organizational structure with advanced concepts, continuously improve their own capabilities, and put forward requirements for improving the system, technological progress, incentive application, and effective training. In the discussion with the cable company and the peak health management team, Yu Jianhong hoped that the cable company would always keep its energy, seize the market, grasp production, promote management, and strive to continue to achieve profits. Peak health to establish product positioning, in the marketing model to explore new ways, in the cost, procurement, technology and other aspects of the establishment of advantages. (Ni Yingzhen, Fangsi, Zhang Zhijian)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page